InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,436.44
(
-0.50%
)
US TECH 100
18,394.40
(
-0.87%
)
Dow Jones
40,743.33
(
0.50%
)
Brent Oil
78.54
(
-0.03%
)
Bitcoin
66,324.54
(
0.23%
)

Replies to post #31813 on Ayala Pharmaceuticals Inc (ADXS)

Replies to #31813 on Ayala Pharmaceuticals Inc (ADXS)
icon url

gajj

08/31/17 7:09 PM

#31816 RE: Meishairwin #31813

time is on our side. patience
icon url

James salmon

08/31/17 7:45 PM

#31820 RE: Meishairwin #31813

One major event you are missing, and that's EU approval.
icon url

ignatiusrielly35

08/31/17 10:20 PM

#31843 RE: Meishairwin #31813

Totally ignoring the prospect of accelerated approval by the EMA. And the interim results on AIM2Cerv are more likely due in 2018, not 2019. What do you think the stock should be at now, i.e., fair value? Can you see it trading in the 20's well before interim results from the current P3?
icon url

smasse

08/31/17 10:57 PM

#31850 RE: Meishairwin #31813

Meish, how does kite stand up to your ideas on development/approval and sale to BP? Did they have same FDA approvals you are saying advaxis should have before a buyout?